DELIVERING NEXT LEVEL HEALTHCARE Direct-to-X services: diverse, fast, and agile #WeCare
Direct-to-X services enable patient-centric care models by delivering all categories of treatments, products, and clinical kits to an increasingly varied range of patient, consumer, and end-user locations.
Our global logistics infrastructure enables pharmaceutical, medical device, clinical trials, and consumer health organizations to develop segmented supply chains with a range of Direct-to-X models which are diverse, fast, and agile.
With more than 20 years’ experience serving the life science & healthcare industry and even longer for other industries with long-established direct distribution models, DHL has the expertise, capability, and global infrastructure to design, implement, operate, and improve all aspects of your direct-to-X supply chain.
DHL has an established suite of products and solutions fulfilling the needs of all sectors within the life sciences & healthcare industry, whether bypassing wholesalers or delivering directly to doorstep.
89% of Clinical Trial sponsors use technology to enable a decentralized model with direct to participant deliveries
wider variety of end-user settings.
Consumer trends create demand for new, patient-centric value chains in healthcare, capable of delivering drugs and medical devices to a much wider variety of end-user settings.
Direct-to-Patient (DTP) market is projected to grow at a CAGR of 6.1% until 2032